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Abstract
© 2016,  Media  Sphera.  All  rights  reserved.Objective.  To  study the impact  of  combination
therapy with mexidol and cerebrolysin on the clinical status of patients with chronic cerebral
ischemia (CCI), II stage, in ambulatory conditions. Material and methods. The study included 36
patients with CCI, II stage. In addition to basic therapy, patients received two courses of the
mexidol/cerebrolysin combination during 6 weeks with 3 month-interval between the courses.
The dynamics of subjective complaints of the patients and objective clinical signs was assessed
after each course. The content of 13 chemical elements in the hair was determined by atomic-
emission method after the treatment. Results and ?onclusion/ Based on the results of clinical
and neurological study, the efficacy of combination therapy with mexidol and cerebrolysin as
long-term neuroprotection drugs was shown which manifested a significant reduction in the
severity of all major symptoms under the influence of the therapy.
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